Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs1

Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs1

Bibliographic Details
Main Authors:	Z R Aisanov, E N Kalmanova, A G Chuchalin
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2004-12-01
Series:	Терапевтический архив
Subjects:	lecture cardiovascular diseases combination treatment cholinolytics
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29976

Similar Items

POSITIVE CLINICAL EFFECTS OF AN M-CHOLINOLYTIC IN IDIOPATHIC ARTERIAL HYPOTENSION
by: V. M. Baev, et al.
Published: (2018-03-01)

M-cholinolytics and prescription of therapy in urge syndrome
by: V V Danilov, et al.
Published: (2013-02-01)

Place of M-cholinolytics in the medical and diagnostic technology of handling women with urinary incontinence
by: V V Danilov, et al.
Published: (2014-08-01)

Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation
by: S. К. Zyryanov, et al.
Published: (2022-07-01)

Overactive bladder in women with stress urinary incontinence
by: A. I. Neymark, et al.
Published: (2014-11-01)

Overactive bladder in women with stress urinary incontinence
by: A. I. Neymark, et al.
Published: (2014-11-01)

Central anticholinergic syndrome (CAS) in anesthesiology: a narrative review
by: Dmytro Dmytriiev, et al.
Published: (2019-06-01)

Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome
by: Fadda V, et al.
Published: (2016-04-01)

Chronic obstructive pulmonary disease and cardiovascular co-morbidities
by: Domenico Panuccio, et al.
Published: (2013-05-01)

THE ROLE OF ENDOTHELIAL DYSFUNCTION AND ARTERIAL RIGIDITY IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M A Makarova, et al.
Published: (2012-03-01)

Early cardiovascular involvement in Chronic Obstructive Pulmonary Disease
by: M. Malerba, et al.
Published: (2016-01-01)

Interaction of Drugs Used for the Treatment of Cardiovascular Diseases
by: Galina N. Kovalskaya, et al.
Published: (2019-04-01)

Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease
by: Almagro P, et al.
Published: (2020-04-01)

Chronic Obstructive Pulmonary Disease as a Cardiovascular Diseases Risk Factor in Erbil
by: Goran Abubaker Osman, et al.
Published: (2019-11-01)

Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
by: Irina E. Chazova, et al.
Published: (2020-10-01)

Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases
by: Kartik Deshmukh, et al.
Published: (2021-01-01)

Exacerbation and Cardiovascular Events in Eosinophilic Chronic Obstructive Pulmonary Disease
by: Mami Orimo, et al.
Published: (2023-04-01)

Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease
by: Kim EK, et al.
Published: (2024-01-01)

Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease
by: Yanjing He, et al.
Published: (2017-09-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics
by: L. G. Ambatiello, et al.
Published: (2020-03-01)

Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease
by: N. V. Bagisheva, et al.
Published: (2021-10-01)

New combined assessment of chronic obstructive pulmonary disease: Utilization, pitfalls, and association with spirometry
by: Ruchi Dua, et al.
Published: (2019-01-01)

The Role of Inhalatory Corticosteroids and Long Acting β2 Agonists in the Treatment of Patients Admitted to Hospital Due to Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Aecopd)
by: Bakir Mehić
Published: (2007-11-01)

Inhalatory delirium – the way out
by: Michał Pirożyński
Published: (2015-12-01)

Health-Screening-Based Chronic Obstructive Pulmonary Disease and Its Effect on Cardiovascular Disease Risk
by: Sang-Jun Lee, et al.
Published: (2022-06-01)

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease
by: Joon Young Choi, et al.
Published: (2022-04-01)

Choosing a Lecture Format in Higher Pharmaceutical Education
by: Tatiana Semenova, et al.
Published: (2022-07-01)

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin
by: Imane Achir Alispahic, et al.
Published: (2024-03-01)

Pulmonary comorbidities associated with chronic obstructive pulmonary disease
by: Fabrizio Luppi, et al.
Published: (2012-12-01)

Fixed dose long-acting bronchodilator combinations in chronic obstructive pulmonary disease: safety, effectiveness and cardiovascular system
by: I. V. Leshchenko
Published: (2018-10-01)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
by: Matera MG, et al.
Published: (2016-01-01)

Dyslipidemiaand chronic progressive diseases of the kidneys
by: I В Kolina, et al.
Published: (2004-09-01)

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
by: Fu-Shun Yen, et al.
Published: (2022-08-01)

comparing effect of two combined training method and lecture on puberty health on awareness level of high school girls in Masjed Soleiman
by: Shila khedri, et al.
Published: (2019-02-01)

Comboridity of chronic obstructive pulmonary disease and cardiovascular diseases: general factors, pathophysiological mechanisms and clinical significance
by: A. M. Chaulin, et al.
Published: (2020-05-01)

Cardiovascular comorbidities associated with patients with chronic obstructive pulmonary disease – a hospital-based study
by: Amit S. Gupta, et al.
Published: (2020-01-01)

Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
by: Ruth Webster, et al.
Published: (2020-08-01)

Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease
by: A. M. Chaulin, et al.
Published: (2021-05-01)

Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease
by: Xiao-Fang Li, et al.
Published: (2022-11-01)